ResMed
RMD
#621
Rank
A$56.68 B
Marketcap
A$388.33
Share price
2.00%
Change (1 day)
5.30%
Change (1 year)
Categories

ResMed (RMD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$3.31 Billion

According to ResMed's latest financial reports the company's total liabilities are A$3.31 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ResMed - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30A$3.00 B-23.51%
2023-06-30A$3.93 B56.4%
2022-06-30A$2.51 B2.37%
2021-06-30A$2.45 B-18.86%
2020-06-30A$3.02 B4.5%
2019-06-30A$2.89 B113.5%
2018-06-30A$1.35 B-30.9%
2017-06-30A$1.96 B-6.31%
2016-06-30A$2.09 B171.39%
2015-06-30A$0.77 B20.88%
2014-06-30A$0.63 B-2.78%
2013-06-30A$0.65 B27%
2012-06-30A$0.51 B64.07%
2011-06-30A$0.31 B-21.13%
2010-06-30A$0.40 B-17.6%
2009-06-30A$0.48 B43.22%
2008-06-30A$0.33 B-10.52%
2007-06-30A$0.37 B4.15%
2006-06-30A$0.36 B-7.5%
2005-06-30A$0.39 B44.74%
2004-06-30A$0.27 B4.79%
2003-06-30A$0.25 B-20.58%
2002-06-30A$0.32 B-11%
2001-06-30A$0.36 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Medtronic
MDT
A$64.84 B 1,858.72%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
A$78.50 B 2,271.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Masimo
MASI
A$1.52 B-53.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Allied Healthcare Products
AHPI
A$21.85 M-99.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Inogen
INGN
A$0.16 B-94.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Philips
PHG
A$27.98 B 745.46%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands